Stockler MR - Search Results

1

Preferences for Immunotherapy in Melanoma: A Systematic Review.

Livingstone A, Agarwal A, Stockler MR, Menzies AM, Howard K, Morton RL. Livingstone A, et al. Among authors: stockler mr. Ann Surg Oncol. 2020 Feb;27(2):571-584. doi: 10.1245/s10434-019-07963-y. Epub 2019 Oct 29. Ann Surg Oncol. 2020. PMID: 31664622 Review.

2

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.

Duric V, Stockler M. Duric V, et al. Lancet Oncol. 2001 Nov;2(11):691-7. doi: 10.1016/S1470-2045(01)00559-9. Lancet Oncol. 2001. PMID: 11902540 Review.

3

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.

Nowak AK, Wilcken NR, Stockler MR, Hamilton A, Ghersi D. Nowak AK, et al. Among authors: stockler mr. Lancet Oncol. 2004 Jun;5(6):372-80. doi: 10.1016/S1470-2045(04)01494-9. Lancet Oncol. 2004. PMID: 15172358 Review.

4

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

Nowak AK, Stockler MR, Chow PK, Findlay M. Nowak AK, et al. Among authors: stockler mr. Cancer. 2005 Apr 1;103(7):1408-14. doi: 10.1002/cncr.20963. Cancer. 2005. PMID: 15744746 Free article. Review.

5

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA, Beith J, Boyle F, Friedlander ML. Thewes B, et al. Among authors: stockler mr. Lancet Oncol. 2005 Aug;6(8):581-8. doi: 10.1016/S1470-2045(05)70254-0. Lancet Oncol. 2005. PMID: 16054569 Clinical Trial.

6

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Duric VM, Stockler MR, Heritier S, Boyle F, Beith J, Sullivan A, Wilcken N, Coates AS, Simes RJ. Duric VM, et al. Among authors: stockler mr. Ann Oncol. 2005 Nov;16(11):1786-94. doi: 10.1093/annonc/mdi370. Epub 2005 Aug 26. Ann Oncol. 2005. PMID: 16126738 Free article. Clinical Trial.

7

Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?

Duric VM, Fallowfield LJ, Saunders C, Houghton J, Coates AS, Stockler MR. Duric VM, et al. Among authors: stockler mr. Br J Cancer. 2005 Dec 12;93(12):1319-23. doi: 10.1038/sj.bjc.6602874. Br J Cancer. 2005. PMID: 16333242 Free PMC article.

8

Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review.

Hauser CA, Stockler MR, Tattersall MH. Hauser CA, et al. Among authors: stockler mr. Support Care Cancer. 2006 Oct;14(10):999-1011. doi: 10.1007/s00520-006-0079-9. Epub 2006 May 18. Support Care Cancer. 2006. PMID: 16708213 Review.

9

Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer.

Duric VM, Butow PN, Sharpe L, Boyle F, Beith J, Wilcken NR, Heritier S, Coates AS, John Simes R, Stockler MR. Duric VM, et al. Among authors: stockler mr. Psychooncology. 2007 Jan;16(1):48-59. doi: 10.1002/pon.1045. Psychooncology. 2007. PMID: 16856128 Clinical Trial.

10

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.

Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR, Wyld D, Abdi EA, Glasgow A, Beale PJ, Jefford M, Dhillon H, Heritier S, Carter C, Hickie IB, Simes RJ; Zoloft's Effects on Symptoms and survival Time Trial Group. Stockler MR, et al. Lancet Oncol. 2007 Jul;8(7):603-12. doi: 10.1016/S1470-2045(07)70148-1. Lancet Oncol. 2007. PMID: 17548243 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page